Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling
Trial ID or NCT#
Status
Purpose
Plasma donor-derived cell-free DNA (dd-cfDNA) is measured as a % of the total plasma cfDNA in association with the measurement of AlloMap, a non-invasive gene expression test to aid in heart transplant management.
Official Title
Utility of Donor-Derived Cell-free DNA in Association With Gene-Expression Profiling (AlloMap®) in Heart Transplant Recipients (D-OAR)
Eligibility Criteria
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Helen Luikart
650-724-2883
View on ClinicalTrials.gov